β-synuclein-derived peptides with neuroprotective activity: An alternative treatment of neurodegenerative disorders?

By Windisch Manfred   Hutter-Paier Birgit   Schreiner Edith   Wronski Robert  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 155-165

Humana Press, Inc

Access to resources Recommend Favorite

New treatment of depression in Parkinson's disease

By Maruyama Tetsuhiro  

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 25-27

Ashgate Publishing Ltd

Access to resources Recommend Favorite

BRIEF COMMUNICATION Mutation in the -Synuclein Gene and Sporadic Parkinson's Disease, Alzheimer's Disease, and Dementia with Lewy Bodies

By Higuchi S.   Arai H.   Matsushita S.   Matsui T.   Kimpara T.   Takeda A.   Shirakura K.  

Experimental Neurology, Vol. 153, Iss. 1, 1998-09 ,pp. : 164-166

Elsevier

Access to resources Recommend Favorite

Novel -Synuclein-Immunoreactive Proteins in Brain Samples from the Contursi Kindred, Parkinson's, and Alzheimer's Disease

By Langston J.W.   Sastry S.   Chan P.   Forno L.S.   Bolin L.M.   Di Monte D.A.  

Experimental Neurology, Vol. 154, Iss. 2, 1998-12 ,pp. : 684-690

Elsevier

Access to resources Recommend Favorite

Cell Degeneration Induced by Amyloid-β Peptides: Implications for Alzheimer's Disease

By Pereira Cláudia   Ferreiro Elisabete   Cardoso Sandra Morais   de Oliveira Catarina Resende  

Journal of Molecular Neuroscience, Vol. 23, Iss. 1-2, 2004-04 ,pp. : 97-104

Humana Press, Inc

Access to resources Recommend Favorite